Jazz Pharmaceuticals plc (Jazz Pharmaceuticals) operates as a biopharmaceutical company.
The company is dedicated to developing life-changing medicines for people with rare diseases—often with limited or no therapeutic options. The company has a div…
Analysis
Middle-of-the-road
Jazz Pharmaceuticals plc is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
The price is fair. You pay 21.8× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 7% yearly growth; analysts expect 55%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is adequate. The company scores 12/20 on our value-creation score: creating some value.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202338
71
2023202420252026
All-time high
87
Feb 2026
All-time low
38
Jan 2023
Average rank
64
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
50
48
52
56
Price/Earnings
51
97
94
90
Price/Book
61
44
48
62
Dividend Yield
1
1
1
1
Value (overall)
41
53
47
62
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.